NL1007839C2 - Formulering en gebruik. - Google Patents

Formulering en gebruik. Download PDF

Info

Publication number
NL1007839C2
NL1007839C2 NL1007839A NL1007839A NL1007839C2 NL 1007839 C2 NL1007839 C2 NL 1007839C2 NL 1007839 A NL1007839 A NL 1007839A NL 1007839 A NL1007839 A NL 1007839A NL 1007839 C2 NL1007839 C2 NL 1007839C2
Authority
NL
Netherlands
Prior art keywords
formulation
dose
bamboo
measured
formulation according
Prior art date
Application number
NL1007839A
Other languages
English (en)
Dutch (nl)
Other versions
NL1007839A1 (nl
Inventor
Hans Nilsson
Carl-Axel Bauer
Staffan Annefors
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NL1007839A1 publication Critical patent/NL1007839A1/xx
Application granted granted Critical
Publication of NL1007839C2 publication Critical patent/NL1007839C2/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
NL1007839A 1996-12-20 1997-12-18 Formulering en gebruik. NL1007839C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604752 1996-12-20
SE9604752A SE9604752D0 (sv) 1996-12-20 1996-12-20 Formulation and use

Publications (2)

Publication Number Publication Date
NL1007839A1 NL1007839A1 (nl) 1998-06-23
NL1007839C2 true NL1007839C2 (nl) 1998-08-31

Family

ID=20405108

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1007839A NL1007839C2 (nl) 1996-12-20 1997-12-18 Formulering en gebruik.

Country Status (24)

Country Link
US (1) US6075048A (el)
EP (1) EP0921795A1 (el)
JP (1) JP2001501225A (el)
KR (1) KR19990082274A (el)
CN (1) CN1210464A (el)
AU (1) AU7871398A (el)
BE (1) BE1011395A5 (el)
BR (1) BR9707574A (el)
CA (1) CA2243085A1 (el)
CZ (1) CZ243898A3 (el)
ES (1) ES2131482B1 (el)
FR (1) FR2757398B1 (el)
GR (1) GR1003207B (el)
HU (1) HUP9901792A3 (el)
ID (1) ID23693A (el)
IE (1) IE970899A1 (el)
IL (1) IL125535A0 (el)
NL (1) NL1007839C2 (el)
NO (1) NO983556D0 (el)
PL (1) PL328334A1 (el)
SE (1) SE9604752D0 (el)
TR (1) TR199801500T1 (el)
WO (1) WO1998027981A1 (el)
ZA (1) ZA9711047B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use
SE9903995D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New combination
WO2006081986A1 (en) * 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Bambuterol and integrin inhibitor combination
CN104784106A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种盐酸班布特罗口服溶液的制备方法
CN104784108A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种盐酸班布特罗口服溶液组合物
CN110898003A (zh) * 2019-12-09 2020-03-24 岳阳新华达制药有限公司 一种新型盐酸班布特罗口服溶液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086363A (en) * 1977-03-16 1978-04-25 Usv Pharmaceutical Corporation Treatment of asthma
ATE7689T1 (de) * 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use

Also Published As

Publication number Publication date
NO983556L (no) 1998-08-03
ID23693A (id) 2000-05-11
FR2757398A1 (fr) 1998-06-26
TR199801500T1 (xx) 1999-02-22
IL125535A0 (en) 1999-03-12
PL328334A1 (en) 1999-01-18
ES2131482A1 (es) 1999-07-16
CN1210464A (zh) 1999-03-10
EP0921795A1 (en) 1999-06-16
WO1998027981A1 (en) 1998-07-02
CA2243085A1 (en) 1998-07-02
HUP9901792A2 (hu) 1999-10-28
ES2131482B1 (es) 2000-03-01
GR970100486A (el) 1998-08-31
GR1003207B (el) 1999-09-14
NL1007839A1 (nl) 1998-06-23
SE9604752D0 (sv) 1996-12-20
HUP9901792A3 (en) 2000-04-28
KR19990082274A (ko) 1999-11-25
FR2757398B1 (fr) 2000-09-01
NO983556D0 (no) 1998-08-03
BR9707574A (pt) 1999-07-27
AU7871398A (en) 1998-07-17
CZ243898A3 (cs) 1998-11-11
BE1011395A5 (fr) 1999-08-03
JP2001501225A (ja) 2001-01-30
IE970899A1 (en) 1998-10-07
ZA9711047B (en) 1998-06-22
US6075048A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
US6702997B2 (en) Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
AU2002347948A1 (en) Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
PL175988B1 (pl) Pastylka nikotynowa
SK74496A3 (en) Organoleptically acceptable oral pharmaceutical compositions
KR960011772B1 (ko) 개선된 디데옥시 퓨린 뉴클레오사이드 경구 투여 제제
JPH0432802B2 (el)
JPH0517345A (ja) 経口摂取可能な活性成分のための非アルコール性供給系
CA2659245A1 (en) Anti-migraine oral spray formulations and methods
KR19990008253A (ko) 아목시실린 및 클라불란산을 함유하는 조성물
McCarron et al. Diphenoxylate-atropine (Lomotil) overdose in children: an update (report of eight cases and review of the literature)
MX2010011701A (es) Formulacion liquida para deferiprona con gusto agradable al paladar.
NL1007839C2 (nl) Formulering en gebruik.
CA2575706A1 (en) Vitamin b12 compositions
CN110869003A (zh) 一种不含防腐剂的固体剂型氨己烯酸药物组合物
JP2004161679A (ja) 内服用液剤
KR100395864B1 (ko) 트리메부틴을함유하는신규제약조성물및그제조방법
WO2019174755A1 (en) Oral solutions comprising tramadol and acetaminophen
DE60112584T2 (de) Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit
US20030140920A1 (en) Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
WO2017109547A1 (es) Premezcla y composición farmacéutica para la administración oral de memantina como suspensión permanente o de preparación previa a la administración al paciente y optativamente por sonda de alimentación enteral y procedimientos correspondientes
US20050175544A1 (en) Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
WO2020208398A1 (es) Composición farmacéutica en polvo con memantina y donepecilo para utilizar en el tratamiento de la enfermedad de alzheimer
EP3773533A1 (en) Liquid dosage forms of cinacalcet or salt thereof
NL2024160B1 (en) Pharmaceutical liquid composition, kit of parts comprising the pharmaceutical liquid composition, and method for preparing the pharmaceutical liquid composition
Dawson et al. Guidelines for compounding oral medications for pediatric patients

Legal Events

Date Code Title Description
AD1B A search report has been drawn up
PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20040701